BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, April 20, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 3, 2013
View Archived Issues
New small-molecule enzymatic inhibitors targeting primary human tumors
Read More
Adenovirus-based immunotherapy for chronic hepatitis B
Read More
New electrochemical immunosensor for diagnosis of inflammatory intestinal disease
Read More
Yakult Honsha synthesizes novel protein kinase inhibitors
Read More
French team presents new caspase activators
Read More
BioSavita and Quanta BioDesign enter collaboration to BioSuperior therapeutics
Read More
Dana-Farber and Evotec form oncology collaboration focusing on epigenetic targets
Read More
Servier to use Afraxis' ESP Technology for drug discovery
Read More
CCT-271850 demonstrates in vitro and in vivo activity
Read More
Tolero acquires worldwide license to Sanofi's alvocidib
Read More
OGX-427 to be studied as part of combination therapy for pancreatic cancer
Read More
Genentech evaluates antibody-drug conjugate for lung and ovarian cancer
Read More
Ligand acquires financial rights to portfolio of programs from Selexis
Read More
FDA approves use of Actemra in polyarticular juvenile idiopathic arthritis
Read More
FDA approves Raptor Pharmaceutical's treatment for nephropathic cystinosis
Read More
FDA issues complete response letter declining approval of Probuphine
Read More
Roche discloses new CRAC modulators
Read More
Novel PDE10A inhibitors prepared by Lundbeck
Read More
Enanta Pharmaceuticals synthesizes novel HCV NS5A inhibitors
Read More
Ascletis Pharmaceuticals obtains rights to HIV drug in China
Read More
DiaMedica begins first-in-human trial of DM-199
Read More
Forest Laboratories and Almirall report data from phase III AUGMENT COPD study
Read More
Daratumumab receives FDA breakthrough therapy designation
Read More
Vyvanse obtains FDA approval for maintenance treatment in children with ADHD
Read More
Omadacycline receives another QIDP designation
Read More
FDA committee votes against approval of tivozanib
Read More